Orthofix Medical (OFIX) Long-Term Deferred Tax (2010 - 2022)

Orthofix Medical (OFIX) has 13 years of Long-Term Deferred Tax data on file, last reported at $1.5 million in Q3 2022.

• For the quarter ending Q3 2022, Long-Term Deferred Tax fell 93.21% year-over-year to $1.5 million; the trailing twelve-month figure through Sep 2022 stood at $1.5 million (down 93.21% YoY), and the FY2021 full-year result was $1.8 million, down 92.93% from the prior year.
• Long-Term Deferred Tax for Q3 2022 stood at $1.5 million, up from $1.5 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $39.6 million in Q3 2019 and bottomed at $1.5 million in Q2 2022.
• A 5-year average of $25.8 million and a median of $30.6 million in 2018 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax soared 42.52% in 2018 and slumped 93.21% in 2022, its largest moves.
• Tracing OFIX's Long-Term Deferred Tax over 5 years: stood at $33.2 million in 2018, then rose by 5.68% to $35.1 million in 2019, then decreased by 28.69% to $25.0 million in 2020, then plunged by 92.93% to $1.8 million in 2021, then fell by 12.82% to $1.5 million in 2022.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $1.5 million, $1.5 million, and $1.9 million for Q3 2022, Q2 2022, and Q1 2022 respectively.

Peer Comparison